We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.49B
AUM Growth
+$329M
(+5.3%)
Cap. Flow
+$1.05B
Cap. Flow
% of AUM
16.14%
Top 10 Holdings %
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$112M |
| 2 |
Skyworks Solutions
SWKS
|
+$103M |
| 3 |
STMicroelectronics
STM
|
+$87.3M |
| 4 |
ASML
ASML
|
+$71.6M |
| 5 |
Palo Alto Networks
PANW
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$169M |
| 2 |
Cooper Companies
COO
|
+$103M |
| 3 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$102M |
| 4 |
Lam Research
LRCX
|
+$78.9M |
| 5 |
KLA
KLAC
|
+$76.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.94% |
| 2 | Technology | 31.31% |
| 3 | Financials | 8.29% |
| 4 | Industrials | 7.52% |
| 5 | Communication Services | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
MannKind Corp
MNKD
$1.17B
| – | – |
-236,916
| Closed | -$872K |
|
852
Maravai LifeSciences
MRVI
$947M
| – | – |
-30,517
| Closed | -$1.08M |
|
853
Neurocrine Biosciences
NBIX
$16.7B
| – | – |
-259,635
| Closed | -$24.3M |
|
854
Netflix
NFLX
$305B
| – | – |
-524,480
| Closed | -$19.6M |
|
855
NerdWallet
NRDS
$599M
| – | – |
-10,000
| Closed | -$120K |
|
856
Nerdy
NRDY
$108M
| – | – |
-2,297,088
| Closed | -$11.7M |
|
857
Nurix Therapeutics
NRIX
$2.41B
| – | – |
-219,281
| Closed | -$3.07M |
|
858
NextCure
NXTC
$17.9M
| – | – |
-13,470
| Closed | -$786K |
|
859
Oric Pharmaceuticals
ORIC
$1.1B
| – | – |
-29,095
| Closed | -$155K |
|
860
Otis Worldwide
OTIS
$27.5B
| – | – |
-96,213
| Closed | -$7.4M |
|
|
PARA
861
DELISTED
Paramount Global Class B
PARA
| – | – |
-82,529
| Closed | -$3.12M |
|
862
Penumbra
PEN
$12.7B
| – | – |
-58,345
| Closed | -$13M |
|
863
Parker-Hannifin
PH
$126B
| – | – |
-74,357
| Closed | -$21.1M |
|
864
Playtika
PLTK
$1.54B
| – | – |
-951,517
| Closed | -$18.4M |
|
865
Privia Health
PRVA
$3B
| – | – |
-110,553
| Closed | -$2.96M |
|
|
RPC
866
Ridgepost Capital
RPC
$1B
| – | – |
-75,000
| Closed | -$909K |
|
867
Qualcomm
QCOM
$159B
| – | – |
-268,660
| Closed | -$41.1M |
|
868
Qorvo
QRVO
$7.89B
| – | – |
-305,247
| Closed | -$37.9M |
|
869
Rocket Pharmaceuticals
RCKT
$372M
| – | – |
-142,011
| Closed | -$2.25M |
|
870
Arcus Biosciences
RCUS
$3.47B
| – | – |
-261,419
| Closed | -$8.25M |
|
871
Roku
ROKU
$21.6B
| – | – |
-24,592
| Closed | -$3.08M |
|
872
Rapid Micro Biosystems
RPID
$106M
| – | – |
-130,600
| Closed | -$887K |
|
|
SAGE
873
DELISTED
Sage Therapeutics
SAGE
| – | – |
-77,866
| Closed | -$2.58M |
|
874
Sera Prognostics
SERA
$82.2M
| – | – |
-69,095
| Closed | -$262K |
|
875
Silicon Laboratories
SLAB
$7.19B
| – | – |
-70,709
| Closed | -$10.6M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.
- Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
- Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
- Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
- Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
- Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
- Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
- Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.
Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.